Julie Leblanc, Ph.D.

Expertise

Radiobiology, Radiation Protection, Biochemistry, Cell and Molecular Biology, Developmental Biology, Risk Communication

Preferred language

English or French

Roles and responsibilities

Julie Leblanc is a radiation and health sciences officer at the Canadian Nuclear Safety Commission (CNSC). She provides technical support on behalf of and to the Commission on the subject of radiobiology and low dose radiation risk. She conducts and coordinates low dose radiation research and disseminates objective technical, scientific and regulatory information to the Canadian public, Indigenous groups and other stakeholders. She is also a member and strong supporter of the CNSC Women in STEM tiger team. Her role with COHERE is as a coordinator and researcher, and she is a member of both the COHERE Scientific Committee and the Communications Committee. She is also an International Commission on Radiological Protection mentee and a member of Task Group 111.

Current research and/or projects

  • Conducting the systematic review of how biological sex modifies the risk of ionizing radiation-induced health effects
  • Developing an adverse outcome pathway (AOP) relevant to uranium-induced kidney toxicity

Education

  • BSc with a specialization in Biochemistry, University of Ottawa
  • PhD with a specialization in Biochemistry, University of Ottawa

Affiliations

  • Member of the Canadian Radiation Protection Association and the Radiation Research Society

Awards

  • CNSC Bravo Award for Dedication and Professionalism for writing the Commission Member Document The Biological Mechanisms Acting at Low Doses of Radiation, submitted in combination with an excellent presentation to the Commission (2017)

Key publications

Leblanc, J. & Burtt, J. Radiation biology and its role in the Canadian radiation protection framework. Health Physics. 117:3, 319-329.

Leblanc, J. & Bijlani, D. Health Canada and the Canadian Nuclear Safety Commission: Partners in Low-Dose-Radiation Research in Canada and Abroad. Canadian Radiation Protection Association Bulletin. Feb 26 2019.

Chauhan, V; Said, Z; Daka, J; Sadi, B; Bijlani, D; Marchetti, F; Beaton, D; Gaw, A; Li, C; Burtt, J; Leblanc, J;  Desrosiers, M; Stuart, M; Brossard, M; Vuong, N; Wilkins, R; Qutob, S; McNamee, J; Wang, Y; & Yauk, C. Is there a role for the adverse outcome pathway framework to support radiation protection? International Journal of Radiation Biology. 95:2, 225-232.

Guéguen, Y; Priest, N.; Dublineau, I.; Bannister, L.; Benderitter, M.; Durand, C; Ebrahimian, T.; Grégoire, E.; Grison, S.; Ibanez, C.; Legendre, A.; Lestaevel, P.; Roch-Lefèvre, S.; Roy, L.; Tack, K.; Wyatt, H.; Leblanc, J.; Jourdain, J.R.; Klokov, D. In vivo animal studies help achieve international consensus on standards and guidelines for health risk estimates for chronic exposure to low levels of tritium in drinking water. Environmental and Molecular Mutagenesis. 59(7): 586-594.

Li, R.; Leblanc, J.; He, K.; Liu, X.J. Spindle Function in Xenopus Oocytes Involves Possible Nanodomain Calcium Signaling. Molecular Biology of the Cell. Aug 31 2016. E16-05-0338.

Leblanc, J. et al. The Small GTPase Cdc42 Promotes Membrane Protrusion during Polar Body Emission via ARP2-Nucleated Actin Polymerization. Molecular and Human Reproduction. 2011. 17 (5). 305-316.

Additional links

Date modified: